About Endomag
Endomag is a company based in Cambridge (United Kingdom) founded in 2007 was acquired by Hologic in April 2024. Endomag has raised $44.52 million across 9 funding rounds from investors including Gov.uk, Hologic and Draper Esprit. Endomag offers products and services including Sentimag, MagseedPro, Magseed, and Magtrace. Endomag operates in a competitive market with competitors including Augmedics, Proprio, eCential Robotics, MRI Interventions and Centerline Biomedical, among others.
- Headquarter Cambridge, United Kingdom
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Endomagnetics Ltd
- Date of Incorporation 26 Apr, 2007
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
-
Annual Revenue
$22.58 M (USD)19as on Dec 31, 2022
-
Net Profit
-$5.08 M (USD)-34as on Dec 31, 2022
-
EBITDA
-$6.34 M (USD)-19as on Dec 31, 2022
-
Total Equity Funding
$44.52 M (USD)
in 9 rounds
-
Latest Funding Round
$20.7 M (USD), Series D
Nov 24, 2020
-
Investors
Gov.uk
& 3 more
-
Employee Count
Not available
-
Acquired by
Hologic
(Apr 29, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Endomag
Endomag offers a comprehensive portfolio of products and services, including Sentimag, MagseedPro, Magseed, and Magtrace.
Provides magnetic guidance for breast cancer surgery to enhance precision.
Advanced marker for accurate tumor localization in procedures.
Seed device for identifying breast cancer sites during surgery.
Simple tool for breast cancer staging and treatment planning.
People of Endomag
Unlock access to complete
Funding Insights of Endomag
Endomag has successfully raised a total of $44.52M across 9 strategic funding rounds. The most recent funding activity was a Series D round of $20.7 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Endomag
Endomag has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, Hologic and Draper Esprit.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage agnostic VC firm investing globally
|
Locked | Locked | Locked | |
|
Early-stage venture capital investments are made by Sussex Place Ventures.
|
Locked | Locked | Locked | |
|
Online government services and information are provided to users.
|
Locked | Locked | Locked |
Investor details for Endomag
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Endomag
Investment portfolio details for Endomag
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Endomag
Detailed financials for Endomag
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endomag Comparisons
Peer comparison for Endomag
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Endomag
Endomag operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmedics, Proprio, eCential Robotics, MRI Interventions and Centerline Biomedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Augmented reality systems for guiding surgical procedures are developed.
|
|
| Locked | Locked | Locked |
Visualization systems for surgical procedures are developed using machine learning.
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
MRI-guided minimally invasive procedures for brain and heart are developed.
|
|
| Locked | Locked | Locked |
Developer of surgical navigation and image guidance system for endovascular procedures
|
Detailed competitors of Endomag
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endomag
Complete news archive for Endomag
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endomag
Endomag was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Endomag is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Endomag is a funded company, having raised a total of $44.52M across 9 funding rounds to date.
Annual revenue of Endomag is $22.58M as on Dec 31, 2022.
Endomagnetics has developed a device for tumor identification and detection. The company has developed devices that are Sentimag, a tumor localization system, Magseed markers to localize breast cancer during surgery, and Magtrace lymphatic tracer uses tiny magnetic particles for radiation-free sentinel lymph node biopsies.
Endomag's top competitors include Augmedics, Proprio and ClearPoint Neuro.
Endomag offers Sentimag, MagseedPro, Magseed, and Magtrace.
Endomag has 4 investors. Key investors include Gov.uk, Hologic, Draper Esprit, and Sussex Place Ventures.
The valuation of Endomag is $117.66M as of Nov 2020.